Product Information
DEFERASIROX 360 MG TABLET is a generic product labeled by Ascend Laboratories, LLC, priced at $1.4953 per EA under NDC 67877055430. Its NADAC has been published 215 times since Apr 20, 2022.
The High Outlier badge above means this manufacturer's average price in the Deferasirox market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
360 mg/1
Manufacturer
Ascend Laboratories, LLCNDC
67877055430
Classification
Generic
Dosage Form
TABLET, FILM COATED
Route
ORAL
Last Updated
6/17/2026
Active Ingredients
DEFERASIROXApproval Type
Generic (ANDA)
FDA Application
ANDA210555On Market Since
4/1/2020
Pharmacological Classes
Price Statistics
The NADAC for DEFERASIROX 360 MG TABLET has been published 215 times since Apr 20, 2022, and over the history we have for it it has declined 28.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $1.4953 per EA |
|---|---|
| All-time high | $2.1034 (Apr 12, 2023) |
| All-time low | $1.2249 (Nov 19, 2025) |
| 52-week high | $1.6434 |
| 52-week low | $1.2249 |
| Median price | $1.9685 |
| Average price | $1.7879 |
| Largest weekly change | +29.6% (Mar 18, 2026) |
| Weeks tracked | 215 |
| Tracking since | Apr 20, 2022 |
Generic Alternatives
The matcher finds 4 NADAC-published products sharing this drug's active ingredient, strength, and dosage form across 4 manufacturers (up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Frequently asked questions
What is the NADAC price of DEFERASIROX 360 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for DEFERASIROX 360 MG TABLET, manufactured by Ascend Laboratories, LLC, is $1.4953 per EA (NDC 67877055430), effective Jun 24, 2026.
How has the price of DEFERASIROX 360 MG TABLET changed over time?
Over the history we have for it, the NADAC for DEFERASIROX 360 MG TABLET has declined 28.9%. It has been tracked across 215 weekly CMS publications since Apr 20, 2022.
What are the highest and lowest recorded NADAC prices for DEFERASIROX 360 MG TABLET?
Since Apr 20, 2022, the NADAC for DEFERASIROX 360 MG TABLET has ranged from a low of $1.2249 (Nov 19, 2025) to a high of $2.1034 (Apr 12, 2023), with a median of $1.9685 per EA.
Are there cheaper alternatives to DEFERASIROX 360 MG TABLET?
4 NADAC-published products share the same active ingredient, strength, and dosage form as DEFERASIROX 360 MG TABLET, but none are currently priced below it.
Who manufactures DEFERASIROX 360 MG TABLET?
DEFERASIROX 360 MG TABLET (NDC 67877055430) is labeled by Ascend Laboratories, LLC, and CMS classifies it as a generic product.
Related Drugs
Same classification